Nassib Abou Heidar1, Muhieddine Labban1, Vincent Misrai2, Aurelie Mailhac3, Hani Tamim3, Albert El-Hajj4. 1. Department of Surgery, Division of Urology, American University of Beirut Medical Center, Riad El-Solh, Beirut, 1107 2020, Lebanon. 2. Department of Urology, Clinique Pasteur, Toulouse, France. 3. American University of Beirut Medical Center, Clinical Research Institute, Beirut, Lebanon. 4. Department of Surgery, Division of Urology, American University of Beirut Medical Center, Riad El-Solh, Beirut, 1107 2020, Lebanon. ae67@aub.edu.lb.
Abstract
PURPOSE: To compare the perioperative outcomes associated with laser enucleation of the prostate (LEP) and transurethral resection of the prostate (TURP) using a national database. METHODS: The American College of Surgeons National Surgical Quality Improvement Program database was reviewed for patients who underwent TURP or LEP from 2008 to 2016. Baseline demographics, comorbidities, and predisposition to bleeding were compared between TURP and LEP. The 30-day perioperative outcomes including operative time, length of hospital stay (LOS), return to the operating room (OR), bleeding requiring transfusion, and organ system-specific complications were compared between the procedures. A multivariate logistic regression analysis was performed, adjusting for the type of surgery and other covariates. RESULTS: The series included 37,577 TURP and 2869 LEP procedures. While TURP was associated with a shorter operative time (55.20 ± 37.80 min) than LEP (102.80 ± 62.30 min), the latter was associated with a shorter hospital stay (1.29 ± 2.73 days) than TURP (2.05 ± 5.20 days). Compared to TURP, LEP had 0.52 (0.47-0.58) times the odds of a LOS > 1 day and 0.67 (0.54-0.83) times the odds of developing urinary tract infections. Nevertheless, no difference was found for other postoperative complications, need for transfusion, and return to OR. CONCLUSION: Real-life data from a large national database confirmed that LEP is a safe and reproducible procedure to treat benign prostatic obstruction. Compared to TURP, LEP was associated with a lower rate of infectious complications and a shorter LOS at the expense of an increased operative time.
PURPOSE: To compare the perioperative outcomes associated with laser enucleation of the prostate (LEP) and transurethral resection of the prostate (TURP) using a national database. METHODS: The American College of Surgeons National Surgical Quality Improvement Program database was reviewed for patients who underwent TURP or LEP from 2008 to 2016. Baseline demographics, comorbidities, and predisposition to bleeding were compared between TURP and LEP. The 30-day perioperative outcomes including operative time, length of hospital stay (LOS), return to the operating room (OR), bleeding requiring transfusion, and organ system-specific complications were compared between the procedures. A multivariate logistic regression analysis was performed, adjusting for the type of surgery and other covariates. RESULTS: The series included 37,577 TURP and 2869 LEP procedures. While TURP was associated with a shorter operative time (55.20 ± 37.80 min) than LEP (102.80 ± 62.30 min), the latter was associated with a shorter hospital stay (1.29 ± 2.73 days) than TURP (2.05 ± 5.20 days). Compared to TURP, LEP had 0.52 (0.47-0.58) times the odds of a LOS > 1 day and 0.67 (0.54-0.83) times the odds of developing urinary tract infections. Nevertheless, no difference was found for other postoperative complications, need for transfusion, and return to OR. CONCLUSION: Real-life data from a large national database confirmed that LEP is a safe and reproducible procedure to treat benign prostatic obstruction. Compared to TURP, LEP was associated with a lower rate of infectious complications and a shorter LOS at the expense of an increased operative time.
Entities:
Keywords:
Benign prostatic obstruction; Laser enucleation of the prostate; Prostatic adenoma; Transurethral resection of the prostate
Authors: Stefan W Leichtle; Nicolas J Mouawad; Richard Lampman; Bonita Singal; Robert K Cleary Journal: J Am Coll Surg Date: 2011-02 Impact factor: 6.113
Authors: Peter J Gilling; Liam C Wilson; Colleen J King; Andre M Westenberg; Christopher M Frampton; Mark R Fraundorfer Journal: BJU Int Date: 2011-08-23 Impact factor: 5.588
Authors: Wen-Chih Wu; Tracy L Schifftner; William G Henderson; Charles B Eaton; Roy M Poses; Georgette Uttley; Satish C Sharma; Michael Vezeridis; Shukri F Khuri; Peter D Friedmann Journal: JAMA Date: 2007-06-13 Impact factor: 56.272
Authors: Jean-Nicolas Cornu; Sascha Ahyai; Alexander Bachmann; Jean de la Rosette; Peter Gilling; Christian Gratzke; Kevin McVary; Giacomo Novara; Henry Woo; Stephan Madersbacher Journal: Eur Urol Date: 2014-06-25 Impact factor: 20.096
Authors: Albert El Hajj; Vincent Misrai; Ali A Nasrallah; Muhieddine L Labban; Jad A Najdi; Enrique Rijo Journal: World J Urol Date: 2022-01-06 Impact factor: 4.226
Authors: Kristian D Stensland; Todd M Morgan; Alireza Moinzadeh; Cheryl T Lee; Alberto Briganti; James W F Catto; David Canes Journal: Eur Urol Date: 2020-04-09 Impact factor: 20.096